Catalyst calendar
Data as of 2026-08-20 01:00 UTC · tracked universe polled every 15 minutes
Three kinds of date: a PDUFA date (the deadline the FDA sets itself to decide on a drug application), an AdCom (an FDA advisory-committee meeting that reviews it in public), and a readout window (when a trial's results are expected). Dates marked confirmed by the company come from an 8-K or press-release quote; our estimate is a rule-derived window off the trial's registered primary-completion date (see methodology) — never shown the same way. Today: 200 estimated readout windows and 0 disclosed PDUFA/AdCom dates.
Next 7 days
| Date | Ticker | Phase | Event |
|---|---|---|---|
| 2028-01-17 in 74w | $AGIO | Phase 1 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and… NCT07241234 |
| 2028-01-26 in 75w | $REGN | Phase 2 | A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab… NCT05557591 |
| 2028-01-31 in 76w | $BIIB | Phase 2 | A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its… NCT07722546 |
| 2028-02-10 in 77w | $BIIB | Phase 2 | A Study to Learn About the Effects of Felzartamab Infusions in Adults With… NCT07219043 |
| 2028-02-16 in 78w | $MRTX | Phase 2 | A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated… NCT07415031 |
| 2028-03-01 in 80w | $IOVA | Phase 3 | Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With… NCT05727904 |
| 2028-03-07 in 81w | $ARGX | Phase 2 | ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy… NCT07284420 |
| 2028-03-31 in 84w | $ALNY | Phase 3 | A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With… NCT06679946 |
| 2028-04-01 in 84w | $ALNY | Phase 2 | A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate… NCT07553442 |
| 2028-06-02 in 93w | $VRTX | Phase 2 | Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With… NCT05312879 |
| 2028-06-19 in 96w | $BIIB | Phase 1 | A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it… NCT07662148 |
| 2028-06-23 in 96w | $BIIB | Phase 3 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its… NCT07444476 |
| 2028-06-30 in 97w | $BMRN | Phase 2 | A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0… NCT07126262 |
| 2028-06-30 in 97w | $AXSM | Phase 3 | A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With… NCT07717892 |
| 2028-06-30 in 97w | $AXSM | Phase 3 | A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD NCT07717879 |
| 2028-07-01 in 97w | $CRSP | Phase 1 | A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants… NCT07758634 |
| 2028-07-05 in 98w | $ALNY | Phase 1 | A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease NCT06585449 |
| 2028-07-28 in 101w | $ARGX | Phase 2 | A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's… NCT07760818 |
| 2028-08-28 in 106w | $SRPT | Phase 1 | A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and… NCT05876780 |
| 2028-09-18 in 109w | $ZEAL | Phase 3 | Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel… NCT07228403 |
| 2028-09-30 in 110w | $ITCI | Phase 2 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of… NCT06540833 |
| 2028-10-23 in 114w | $ZEAL | Phase 3 | Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS NCT07197944 |
| 2028-10-31 in 115w | $MRTX | Phase 2 | Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab… NCT04613596 |
| 2028-11-28 in 119w | $BIIB | Phase 3 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its… NCT07221669 |
| 2028-12-29 in 123w | $VRTX | Phase 2 | Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in… NCT07204275 |